| 臺大學術典藏 |
2021-11-03T02:33:00Z |
Real-world insights into patients with advanced NSCLC and MET alterations
|
Bittoni M.; Yang J.C.-H.; JIN-YUAN SHIH; Peled N.; Smit E.F.; Camidge D.R.; Arasada R.R.; Oksen D.; Boutmy E.; Stroh C.; Johne A.; Carbone D.P.; Paik P.K. |
| 臺大學術典藏 |
2022-02-22T05:34:08Z |
Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
|
Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H. |
| 臺大學術典藏 |
2022-02-23T02:12:18Z |
Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
|
Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H. |
| 國立交通大學 |
2019-04-03T06:37:18Z |
Real-World Neuroimaging Technologies
|
McDowell, Kaleb; Lin, Chin-Teng; Oie, Kelvin S.; Jung, Tzyy-Ping; Gordon, Stephen; Whitaker, Keith W.; Li, Shih-Yu; Lu, Shao-Wei; Hairston, W. David |
| 臺大學術典藏 |
2020-05-26T09:26:29Z |
Real-World or Controlled Clinical Trial Data in Real-World Practice
|
Chih-Hsin Yang;Wu T.-H; Wu T.-H; CHIH-HSIN YANG |
| 國立成功大學 |
2024-05-16 |
Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer
|
Chang;Gee-Chen;Shih;Jin-Yuan;Yu;Chong-Jen;Chao;Heng-Sheng;Yang;Cheng-Ta;Lin;Chien-Chung;Hung;Jen-Yu;Hsiao;Sheng-Yen;Wang;Chin-Chou;Chian;Chih-Feng;Hsia;Te-Chun;Chen;Yuh-Min |
| 國立成功大學 |
2021-07 |
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
|
Tsai;Hong-Ming;Han;Meng-Zhi;Lin;Yih-Jyh;Chang;Ting-Tsung;Chen;Chiung-Yu;Cheng;Pin-Nan;Chuang;Chiao-Hsiung;Wu;I-Chin;Chen;Po-Jun;Kang;Jui-Wen;Chiu;Yen-Cheng;Chiu;Hung-Chih;Chien;Shih-Chieh;Kuo;Hsin-Yu |
| 國立成功大學 |
2021-7 |
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
|
郭欣瑜; Kuo, Shi-Yu; Tsai, Hong-Ming;Han, Meng-Zhi;Lin, Yih-Jyh;Chang, Ting-Tsung;Chen, Chiung-Yu;Cheng, Pin-Nan;Chuang, Chiao-Hsiung;Wu, I-Chin;Chen, Po-Jun;Kang, Jui-Wen;Chiu, Yen-Cheng;Chiu, Hung-Chih;Chien, Shih-Chieh;Kuo, Hsin-Yu |
| 國立成功大學 |
2019-10 |
Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment
|
Su;Po-Lan;Yang;Szu-Chun;Chen;Yi-Lin;Wu;Yi-Lin;Lin;Chia-Ying;Chang;Wei-Yuan;Tseng;Yau-Lin;Lai;Wu-Wei;Ho;Chung-Liang;Lin;Chien-Chung;Su;Wu-Chou |
| 臺大學術典藏 |
2021-09-14T23:18:37Z |
Real-World Outcomes of Patients with Acute Myeloid Leukemia in Taiwan: A Nationwide Population-Based Study, 2011-2015
|
Wang, Chen Yu; Huang, Huai Hsuan; Chen, Ho Min; FEI-YUAN HSIAO; BOR-SHENG KO |
| 臺大學術典藏 |
2022-09-19T03:16:34Z |
Real-World Outcomes of Patients with Acute Myeloid Leukemia in Taiwan: A Nationwide Population-Based Study, 2011-2015
|
Wang C.-Y.; Huang H.-H.; Chen H.-M.; FEI-YUAN HSIAO; Ko B.-S. |
| 臺大學術典藏 |
2020-11-11T00:57:54Z |
Real-world Outcomes of Ultrasonography-guided Interventions in a Tertiary Hospital
|
Liao, Yk;Shyu, Sg;Chueh-Hung Wu; Liao, YK; Shyu, SG; CHUEH-HUNG WU |
| 臺大學術典藏 |
2021-01-21T02:52:29Z |
Real-world outcomes of ultrasonography-guided interventions in a tertiary hospital
|
Liao Y.-K.; SHAW-GANG SHYU; Wu C.-H. |
| 臺大學術典藏 |
2021-11-05T08:01:35Z |
Real-world outcomes of ultrasonography-guided interventions in a tertiary hospital
|
Liao Y.-K.; SHAW-GANG SHYU; Wu C.-H. |
| 臺大學術典藏 |
2021-05-27T02:50:07Z |
Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey)
|
Chuah Y.-Y.; Wu D.-C.; Chuah S.-K.; JYH-CHIN YANG; Lee T.-H.; Yeh H.-Z.; Chen C.-L.; Liu Y.-H.; Hsu P.-I. |
| 臺大學術典藏 |
2022-03-04T08:22:44Z |
Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey)
|
Chuah Y.-Y.; Wu D.-C.; Chuah S.-K.; JYH-CHIN YANG; Lee T.-H.; Yeh H.-Z.; Chen C.-L.; Liu Y.-H.; Hsu P.-I. |
| 國立臺灣海洋大學 |
2017 |
Real-World RESTful Service Composition: A Transformation-Annotation-Discovery Approach
|
Shang-Pin Ma;Hsuan-Ju Lin;Ci-Wei Lan;Wen-Tin Lee;Ming-Jen Hsu |
| 國立臺灣海洋大學 |
2017 |
Real-World RESTful Service Composition: A Transformation-Annotation-Discovery Approach
|
Shang-Pin Ma;Hsuan-Ju Lin;Ci-Wei Lan;Wen-Tin Lee;Ming-Jen Hsu |
| 國立成功大學 |
2021 |
Real-world results of immune checkpoint inhibitors from the taiwan national health insurance registration system
|
Hsieh, S.-T.;Ho, Ho H.-F.;Tai, H.-Y.;Chien, L.-C.;Chang, H.-R.;Chang, H.-P.;Huang, Y.-W.;Huang, J.-J.;Lien, H.-J.;Huang, L.-Y.;Lee, P.-C. |
| 國立成功大學 |
2021 |
Real-world results of immune checkpoint inhibitors from the Taiwan National Health Insurance Registration System
|
Hsieh;S-T;Ho;H-F;Tai;H-Y;Chien;L-C;Chang;H-R;Chang;H-P;Huang;Y-W;Huang;J-J;Lien;H-J;Huang;L-Y;Lee;P-C |
| 臺大學術典藏 |
2020-03-05T06:05:26Z |
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
|
Lin S.-Y.; Kuo C.-H.; Yeh S.-J.; LI-KAI TSAI; Liu Y.-B.; Huang C.-F.; Tang S.-C.; Jeng J.-S. |
| 臺大學術典藏 |
2020-03-05T05:37:43Z |
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
|
Lin S.-Y.;Kuo C.-H.;Shin-Joe Yeh;Tsai L.-K.;Liu Y.-B.;Huang C.-F.;Tang S.-C.;Jeng J.-S.; Lin S.-Y.; Kuo C.-H.; SHIN-JOE YEH; Tsai L.-K.; Liu Y.-B.; Huang C.-F.; Tang S.-C.; Jeng J.-S. |
| 臺大學術典藏 |
2020-03-02T12:10:28Z |
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
|
Lin S.-Y; Kuo C.-H; Yeh S.-J; Tsai L.-K; Liu Y.-B; Huang C.-F; SUNG-CHUN TANG; Jeng J.-S. |
| 臺大學術典藏 |
2020-03-04T05:42:30Z |
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
|
Lin S.-Y; Kuo C.-H; Yeh S.-J; Tsai L.-K; Liu Y.-B; Huang C.-F; SUNG-CHUN TANG; Jeng J.-S. |
| 臺大學術典藏 |
2020-11-03T11:07:55Z |
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
|
Lin S.-Y.;Kuo C.-H.;Yeh S.-J.;Tsai L.-K.;Liu Y.-B.;Huang C.-F.;Sung-Chun Tang;Jeng J.-S.; Lin S.-Y.; Kuo C.-H.; Yeh S.-J.; Tsai L.-K.; Liu Y.-B.; Huang C.-F.; SUNG-CHUN TANG; Jeng J.-S. |
| 臺大學術典藏 |
2021-07-08T08:19:41Z |
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
|
SHIN YI LIN; Kuo C.-H.; Yeh S.-J.; Tsai L.-K.; Liu Y.-B.; Huang C.-F.; Tang S.-C.; Jeng J.-S. |
| 臺大學術典藏 |
2020-11-03T12:37:38Z |
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
|
Jeng J.-S.; Tang S.-C.; Huang C.-F.; Liu Y.-B.; LI-KAI TSAI; Yeh S.-J.; Kuo C.-H.; Lin S.-Y.; Lin S.-Y.;Kuo C.-H.;Yeh S.-J.;Li-Kai Tsai;Liu Y.-B.;Huang C.-F.;Tang S.-C.;Jeng J.-S. |
| 臺大學術典藏 |
2021-06-04T06:23:03Z |
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
|
Lin S.-Y.;Ching-Hua Kuo;Yeh S.-J.;Tsai L.-K.;Liu Y.-B.;Huang C.-F.;Tang S.-C.;Jeng J.-S.; Lin S.-Y.; CHING-HUA KUO; Yeh S.-J.; Tsai L.-K.; Liu Y.-B.; Huang C.-F.; Tang S.-C.; Jeng J.-S. |
| 臺大學術典藏 |
2021-07-05T07:06:07Z |
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
|
Lin S.-Y.; Kuo C.-H.; Yeh S.-J.; Tsai L.-K.; Liu Y.-B.; CHIH-FEN HUANG; Tang S.-C.; Jeng J.-S. |
| 臺大學術典藏 |
2021-11-26T05:56:25Z |
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
|
Lin S.-Y.; Kuo C.-H.; Yeh S.-J.; LI-KAI TSAI; Liu Y.-B.; Huang C.-F.; Tang S.-C.; Jeng J.-S. |
| 臺大學術典藏 |
2021-12-22T03:53:44Z |
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
|
Lin S.-Y.; Kuo C.-H.; Yeh S.-J.; Tsai L.-K.; Liu Y.-B.; Huang C.-F.; Tang S.-C.; JIANN-SHING JENG |
| 臺大學術典藏 |
2020-12-30T07:47:45Z |
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
|
Lin S.-Y.; Kuo C.-H.; Yeh S.-J.; Tsai L.-K.; YEN BIN LIU; Huang C.-F.; Tang S.-C.; Jeng J.-S. |
| 國立成功大學 |
2020-07-14 |
Real-World Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-Line or Relapse Therapy (ROBOT): 8-Year Experience
|
Wu;Pei-Ying;Cheng;Ya-Min;Shen;Meng-Ru;Chen;Yi-Chun;Huang;Yu-Fang;Chou;Cheng-Yang |
| 國立成功大學 |
2020-07-14 |
Real-world Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-line or Relapse Therapy (ROBOT): 8-year Experience
|
黃于芳; Huang, Yu-Fang; Wu, Pei-Ying;Cheng, Ya-Min;Shen, Meng-Ru;Chen, Yi-Chun;Chou, Cheng-Yang |
| 國立成功大學 |
2024 |
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries
|
Lee;C, -K.;Yoo;C;Hong;J, Y.;Park;S, J.;Kim;J, W.;Tai;D, W.M.;Kim;H;Korphaisarn;K;Tanasanvimon;S;Chen;S, -C.;Kim;J, W.;Kim;I;Kim;M;Choo;J;Oh;S, -B.;Chen;C, -T.;Bae;W, K.;Kim;H;Huh;S, J.;Yen;C, -J.;Park;S;Lee;D, K.;Chan;L, L.L.;Kang;B;Kang;M;Sundar;R;Choi;H, J.;Chan;S, L.;Chon;H, J.;Lee;M, -A. |
| 國家衛生研究院 |
2025-06 |
Real-world use and treatment outcomes of ceftazidime-avibactam in gram-negative bacterial infection in Taiwan: A multicenter retrospective study
|
Yang, TY;Huang, CT;Liu, PY;Lin, YT;Huang, YS;Chang, PH;Tseng, CH;Chang, YT;Lu, PL;Chen, YC |
| 國立成功大學 |
2018-05-10 |
Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan
|
Chang;Yi-Sheng;Lee;Wan-Ju;Lim;Chen-Chee;Wang;Shih-Hao;Hsu;Sheng-Min;Chen;Yi-Chian;Cheng;Chia-Yi;Teng;Yu-Ti;Huang;Yi-Hsun;Lai;Chun-Chieh;Tseng;Sung-Huei |
| 國立成功大學 |
2024-11-05 |
Real-World Validation of the Khorana Risk Score in Predicting Thrombosis for Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
|
Song;Junmin;Chang;Yu-Cheng;Ahn;Jaeun;Chi;Kuan-Yu;Chang;Yu;Chiang;Cho-Han |
| 國立臺灣大學 |
2002 |
Real-world vehicle emissions and VOCs profile in the Taipei tunnel located at Taiwan Taipei area
|
Mei-Yin Hwa; Chu-Chin Hsieh; Tsung-Cheng Wu; Len-Fu W. Chang |
| 國立成功大學 |
2018 |
Real-world geographic variations in the use of cardiac implantable electronic devices—The PANORAMA 2 observational cohort study
|
Bastian, D.;Ebrahim, I.O.;Chen, J.-Y.;Chen, M.-C.;Huang, D.;Huang, J.-L.;Kuznetsov, V.A.;Maus, B.;Naik, A.M.;Verhees, K.J.P.;Fagih, A.R.A.;investigators, on behalf of the PANORAMA 2 |
| 國立臺灣科技大學 |
2013 |
Real6410平台3G網路移植與家庭監控系統之實現
|
鄭伯緯 |
| 臺大學術典藏 |
2020-05-04T07:59:03Z |
REAL: A Risk-Enabled reputation model for electronic commerce.
|
JONATHAN LEE; Lee, Jonathan; Lee, Shin-Jie |
| 臺大學術典藏 |
2021-06-28T06:52:20Z |
Real?world evaluation of modern adjuvant radiotherapy in women with stage ib endometrial cancer
|
Chen J.L.-Y.; Huang C.-Y.; Huang Y.-S.; Hsu C.-Y.; KENG-HSUEH LAN; Shih I.-L.; Cheng W.-F.; Chen C.-A.; Sheu B.-C.; Kuo S.-H. |
| 臺大學術典藏 |
2021-04-30T07:26:49Z |
Real?world evaluation of modern adjuvant radiotherapy in women with stage ib endometrial cancer
|
JENNY LING-YU CHEN; Huang C.-Y.; Huang Y.-S.; Hsu C.-Y.; Lan K.-H.; Shih I.-L.; Cheng W.-F.; Chen C.-A.; Sheu B.-C.; Kuo S.-H. |
| 臺大學術典藏 |
2021-05-04T06:41:32Z |
Real?world evaluation of modern adjuvant radiotherapy in women with stage ib endometrial cancer
|
Chen J.L.-Y.; Huang C.-Y.; YU-SEN HUANG; Hsu C.-Y.; Lan K.-H.; Shih I.-L.; Cheng W.-F.; Chen C.-A.; Sheu B.-C.; Kuo S.-H. |
| 臺大學術典藏 |
2021-06-21T07:27:55Z |
Real?world evaluation of modern adjuvant radiotherapy in women with stage ib endometrial cancer
|
Chen J.L.-Y.; Huang C.-Y.; Huang Y.-S.; CHE-YU HSU; Lan K.-H.; Shih I.-L.; Cheng W.-F.; Chen C.-A.; Sheu B.-C.; Kuo S.-H. |
| 臺大學術典藏 |
2021-10-14T02:45:19Z |
Real?world evaluation of modern adjuvant radiotherapy in women with stage ib endometrial cancer
|
Chen J.L.-Y.; CHAO-YUAN HUANG; Huang Y.-S.; Hsu C.-Y.; Lan K.-H.; Shih I.-L.; Cheng W.-F.; Chen C.-A.; Sheu B.-C.; Kuo S.-H. |
| 臺大學術典藏 |
2022-02-07T07:48:58Z |
Real?world evaluation of modern adjuvant radiotherapy in women with stage ib endometrial cancer
|
Chen J.L.-Y.; Huang C.-Y.; Huang Y.-S.; Hsu C.-Y.; Lan K.-H.; Shih I.-L.; Cheng W.-F.; Chen C.-A.; Sheu B.-C.; SUNG-HSIN KUO |
| 臺大學術典藏 |
2022-05-05T03:09:16Z |
Real?world evaluation of modern adjuvant radiotherapy in women with stage ib endometrial cancer
|
Chen J.L.-Y.; CHAO YUAN HUANG; Huang Y.-S.; Hsu C.-Y.; Lan K.-H.; Shih I.-L.; Cheng W.-F.; Chen C.-A.; Sheu B.-C.; Kuo S.-H. |
| 國立政治大學 |
2010-10 |
Realigning Law and Society in Taiwan
|
王曉丹; Wang, Hsiao-Tan |
